跳至主要内容
临床试验/NCT06298773
NCT06298773尚未招募不适用

SPATIAL PROFILE OF SUBPOPULATIONS OF CANCER AND IMMUNITARY CELLS IN SEVERAL SOLID TUMORS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2024年3月5日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,000
试验地点
1
主要终点
Spatial analysis of cancer cells

研究概览

简要总结

The research project focuses on analyzing the spatial organization of cells within various solid tumors, utilizing advanced technologies enabling in-depth multi-parametric analysis of tumor and immune cells. The primary objective is to understand the spatial distribution of cellular subpopulations within each type of tumor, while secondary objectives include correlating these data with clinical aspects and identifying potential therapeutic targets. The study involves 1000 patients with primary or metastatic tumors and spans a duration of 5 years, from 2024 to 2028. No experimental treatments are planned; rather, only spatial imaging analyses with multiple markers will be conducted. Data analysis involves descriptive statistical methods and hypothesis testing to generate hypotheses for subsequent studies. The analyses will be performed using SPSS® version 21.0 software for Windows®.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male or female subjects aged 18 years
  • primary or metastatic tumors Diagnosed by histology and/or radiological evidence, RNM, or endoscopic
  • signature of informed consent
  • substitute declaration to the consent form where applicable

排除标准

  • previous unrelated tumour disease
  • significant acute or chronic infections (HIV, HCV and HBV infections) and/or ongoing bacterial and viral infections
  • active autoimmune disease
  • pregnant or breastfeeding
  • patients who do not sign informed consent

结局指标

主要结局

Spatial analysis of cancer cells

时间窗: 7 days

Spatial distribution analysis of the main cell subpopulations characterising the tumours studied.

次要结局

  • Identification of therapeutic targets(4 weeks)
  • Comparison of clinical data(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验